Silencing of imprinted CDKN1C gene expression is associated with loss of CpG and histone H3 lysine 9 methylation at DMR-LIT1 in esophageal cancer.
about
Comparative mRNA and microRNA expression profiling of three genitourinary cancers reveals common hallmarks and cancer-specific molecular events.CDKN1C (p57) is a direct target of EZH2 and suppressed by multiple epigenetic mechanisms in breast cancer cellsMicrodeletion of target sites for insulator protein CTCF in a chromosome 11p15 imprinting center in Beckwith-Wiedemann syndrome and Wilms' tumor.Imprinting disruption of the CDKN1C/KCNQ1OT1 domain: the molecular mechanisms causing Beckwith-Wiedemann syndrome and cancer.Expression profile of LIT1/KCNQ1OT1 and epigenetic status at the KvDMR1 in colorectal cancers.Comprehensive and quantitative multilocus methylation analysis reveals the susceptibility of specific imprinted differentially methylated regions to aberrant methylation in Beckwith-Wiedemann syndrome with epimutationsEstrogen-mediated epigenetic repression of the imprinted gene cyclin-dependent kinase inhibitor 1C in breast cancer cells.Epigenetic regulation of mesenchymal stem cells: a focus on osteogenic and adipogenic differentiation.Characterization, tissue expression, and imprinting analysis of the porcine CDKN1C and NAP1L4 genes.Long non-coding RNAs: versatile master regulators of gene expression and crucial players in cancer.PAX3-FOXO1 controls expression of the p57Kip2 cell-cycle regulator through degradation of EGR1.Aberrant promoter methylation and expression of the imprinted PEG3 gene in glioma.Identification of potential therapeutic targets for papillary thyroid carcinoma by bioinformatics analysis.MicroRNA involvement in hepatocellular carcinoma.Loss of imprinting of insulin-like growth factor 2 is associated with increased risk of lymph node metastasis and gastric corpus cancerHistone demethylase JMJD1C regulates esophageal cancer proliferation Via YAP1 signaling.Epigenetic alterations and their clinical implications in esophageal squamous cell carcinoma.Epigenetic and genetic alterations of the imprinting disorder Beckwith-Wiedemann syndrome and related disorders.Linking immunity, epigenetics, and cancer in inflammatory bowel disease.MicroRNA-221 inhibits CDKN1C/p57 expression in human colorectal carcinoma.DNA methylation and histone modifications cause silencing of Wnt antagonist gene in human renal cell carcinoma cell lines.Epigenetic status and aberrant expression of the maspin gene in human hepato-biliary tract carcinomas.Alternative mechanisms associated with silencing of CDKN1C in Beckwith-Wiedemann syndrome.Genetic and epigenetic alterations on the short arm of chromosome 11 are involved in a majority of sporadic Wilms' tumours.A novel de novo point mutation of the OCT-binding site in the IGF2/H19-imprinting control region in a Beckwith-Wiedemann syndrome patient.Oocyte growth-dependent progression of maternal imprinting in mice.
P2860
Q31028410-68682930-8BB3-464B-A1C5-CDC6DD97E241Q33425892-F913FBDC-B4F1-4BAF-B761-22313B41D91FQ33932429-921ECFB5-33F7-45E5-99CB-DA32FF8DC6B1Q34507207-F25D1540-C93F-4C34-8C9C-F65285961245Q34565169-648743C5-C383-4F13-A987-E6108ADC2FAAQ34675182-84B46F16-629A-449E-B0EC-A29593151274Q35020435-43EF3AC1-FFF6-42B4-93B2-7FD9CA63E70DQ35109954-E133EFFF-7445-4444-9EAE-FE59A8E95DD5Q35830464-5E671148-FFEB-4DD3-99EB-B10D48A71A85Q35964148-36755D62-7139-4B38-B1DA-F1D82E81E9E5Q36156793-B94E5F60-1E9F-4FC5-BDCE-FEC94090B099Q36472470-18251A11-1568-4396-8C29-68B0B72E2621Q36502331-8ED5A88E-B527-4FC7-B79E-5522D40CE9F7Q37361575-D108D5C1-1B83-4731-B054-8AE62D832E96Q37365817-6BCD7A8F-C7CD-49E1-B619-F72BB5B68ABAQ37596831-06A420A4-8990-42E9-924B-46DD3E32BDB3Q38093059-B4AC853E-414F-4E23-B9BA-185B772D085AQ38110380-8B46E398-6AC6-4C2C-B57E-784DCDA8003BQ38217532-657E6ED2-07B8-4C60-8B80-EB783C31DB00Q39018578-1572EBEB-2B72-4CFB-A690-F70A029F82A2Q39992913-465A0A8C-6CD5-4CB1-9254-5D7AA91F90BDQ40479195-34FE91D9-5E1D-4D8D-84CD-6B8677FE9931Q42140813-8AADD13A-AE6C-48CF-A04E-324C449504E0Q42277975-DAA3308F-6CF3-43DA-AB9F-304331AB8F8FQ43807044-A7AADE9E-C876-47A3-B095-D8C220EE3618Q50650528-DF069C28-6389-4682-933F-CF67952A993C
P2860
Silencing of imprinted CDKN1C gene expression is associated with loss of CpG and histone H3 lysine 9 methylation at DMR-LIT1 in esophageal cancer.
description
2004 nî lūn-bûn
@nan
2004 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Silencing of imprinted CDKN1C ...... DMR-LIT1 in esophageal cancer.
@ast
Silencing of imprinted CDKN1C ...... DMR-LIT1 in esophageal cancer.
@en
Silencing of imprinted CDKN1C ...... DMR-LIT1 in esophageal cancer.
@nl
type
label
Silencing of imprinted CDKN1C ...... DMR-LIT1 in esophageal cancer.
@ast
Silencing of imprinted CDKN1C ...... DMR-LIT1 in esophageal cancer.
@en
Silencing of imprinted CDKN1C ...... DMR-LIT1 in esophageal cancer.
@nl
prefLabel
Silencing of imprinted CDKN1C ...... DMR-LIT1 in esophageal cancer.
@ast
Silencing of imprinted CDKN1C ...... DMR-LIT1 in esophageal cancer.
@en
Silencing of imprinted CDKN1C ...... DMR-LIT1 in esophageal cancer.
@nl
P2093
P2860
P356
P1433
P1476
Silencing of imprinted CDKN1C ...... DMR-LIT1 in esophageal cancer.
@en
P2093
Hidenobu Soejima
Keiichiro Joh
Ken Higashimoto
Kohji Miyazaki
Makoto Takeuchi
Masahiro Nakayama
Mitsuo Oshimura
Shiroh Matsukura
Takeshi Urano
Tetsuji Nakagawachi
P2860
P2888
P304
P356
10.1038/SJ.ONC.1207576
P407
P577
2004-05-01T00:00:00Z
P5875
P6179
1023532492